// App-Quantinova.ai

: Survival in Patients with Relapsed/Refractory Multiple Myeloma: Outcomes after 4 Years of the Ongoing Multinational Observational Preamble Study

Researchers

Presenter

  • Gordon Cook

Principal Investigators

  • David Cella

  • Clara Chen

  • Catherine Davis

  • Brian GM Durie

  • Hartmut Goldschmidt

  • David J. Kuter

  • Philippe Moreau

  • Ravi Vij

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • Northwestern University, Chicago, IL

  • Bristol-Myers Sqiubb, Princeton, NJ

  • Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA

  • Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany

  • Massachusetts General Hospital Cancer Center, Boston, MA

  • University Hospital Nantes, Nantes, France

  • Washington University School of Medicine, St. Louis, MO

Locations

  • United Kingdom

  • United States

  • Germany

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Multinational

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • NCT01838512

Sponsors

  • Bristol-Myer Squibb

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved